According to Sumitomo Pharma 's latest financial reports the company's total liabilities are $5.08 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-03-31 | $5.46 B | 5.11% |
2022-03-31 | $5.19 B | -13.1% |
2021-03-31 | $5.98 B | 4.14% |
2020-03-31 | $5.74 B | 89.46% |
2019-03-31 | $3.03 B | -9.69% |
2018-03-31 | $3.35 B | 2.32% |
2017-03-31 | $3.28 B | 16.73% |
2016-03-31 | $2.81 B | 29.49% |
2015-03-31 | $2.17 B | -14.25% |
2014-03-31 | $2.53 B | -7.47% |
2013-03-31 | $2.73 B | -5.59% |
2012-03-31 | $2.89 B | -9.36% |
2011-03-31 | $3.19 B | 5.57% |
2010-03-31 | $3.02 B | 348.76% |
2009-03-31 | $0.67 B | -17.32% |
2008-03-31 | $0.81 B | 25.63% |
2007-03-31 | $0.64 B | -26.66% |
2006-03-31 | $0.88 B | 43.83% |
2005-03-31 | $0.61 B |